Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

RNAC

Cartesian Therapeutics Inc

Apr 15 • 04:00PM ET

18.99

Dollar change -0.40
Percentage change -2.06	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO IWO IWC OMFS FESM VTWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-9.71	Insider Own	34.84%	Shs Outstand	5.52M	Perf Week	44.74%
Market Cap	104.82M	Forward P/E	-	EPS next Y	-2.75	Insider Trans	174.80%	Shs Float	3.59M	Perf Month	18.25%
Income	-36.16M	PEG	-	EPS next Q	-0.74	Inst Own	36.82%	Short Float	8.16%	Perf Quarter	-24.36%
Sales	34.53M	P/S	3.04	EPS this Y	93.54%	Inst Trans	-	Short Ratio	7.32	Perf Half Y	-43.48%
Book/sh	11.69	P/B	1.62	EPS next Y	14.66%	ROA	-25.44%	Short Interest	0.29M	Perf Year	-47.69%
Cash/sh	14.42	P/C	1.32	EPS next 5Y	-	ROE	-49.79%	52W Range	11.66 - 42.60	Perf YTD	-8.18%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-52.39%	52W High	-55.42%	Beta	0.58
Dividend TTM	-	Quick Ratio	4.51	Sales past 5Y	-	Gross Margin	94.10%	52W Low	62.79%	ATR (14)	2.38
Dividend Ex-Date	-	Current Ratio	4.51	EPS Y/Y TTM	-168.78%	Oper. Margin	-169.63%	RSI (14)	53.27	Volatility	15.43% 15.04%
Employees	-	Debt/Eq	0.17	Sales Y/Y TTM	-72.13%	Profit Margin	-104.71%	Recom	1.00	Target Price	51.00
Option/Short	No / No	LT Debt/Eq	0.14	EPS Q/Q	-12.61%	Payout	-	Rel Volume	5.01	Prev Close	19.39
Sales Surprise	230.64%	EPS Surprise	-82.22%	Sales Q/Q	-68.37%	Earnings	Mar 07 BMO	Avg Volume	40.06K	Price	18.99
SMA20	5.88%	SMA50	-2.93%	SMA200	-31.37%	Trades		Volume	200,668	Change	-2.06%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-18-23	Downgrade	SVB Securities	Outperform → Market Perform	$1
Jun-14-22	Reiterated	Needham	Buy	$6 → $5
Jun-06-22	Initiated	SVB Leerink	Outperform	$7
Jun-15-21	Initiated	BTIG Research	Buy	$10
Jan-26-21	Upgrade	Mizuho	Neutral → Buy	$2.50 → $8
Oct-01-20	Downgrade	William Blair	Outperform → Mkt Perform
Oct-01-20	Downgrade	Mizuho	Buy → Neutral	$2.50
Jun-12-20	Downgrade	Stifel	Buy → Hold
Apr-28-20	Initiated	H.C. Wainwright	Buy	$8
Jan-29-20	Initiated	Cantor Fitzgerald	Overweight	$10
Jan-21-20	Initiated	William Blair	Outperform
Jun-27-18	Initiated	Janney	Buy	$33
Mar-30-17	Reiterated	UBS	Buy	$26

Show Previous Ratings

Apr-08-24 09:35AM	Down -30.75% in 4 Weeks, Here's Why You Should You Buy the Dip in Cartesian Therapeutics, Inc. (RNAC) (Zacks)
Apr-04-24 07:30AM	Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference (Business Wire)
07:00AM	Cartesian Therapeutics Announces New Employment Inducement Grants (Business Wire)
Apr-02-24 05:41PM	Insiders Are Buying These 11 Penny Stocks (Insider Monkey) -5.36%
Mar-28-24 04:05PM	Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split (GlobeNewswire)
09:35AM	Loading…
Mar-14-24 09:35AM	Cartesian Therapeutics, Inc. (RNAC) Loses -24.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-07-24 11:51PM	RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.04%
07:00AM	Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-06-24 07:00AM	Cartesian Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Mar-05-24 07:05AM	Cartesian Therapeutics Announces New Employment Inducement Grant (GlobeNewswire)
07:00AM	Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland (GlobeNewswire)
Feb-05-24 04:05PM	Cartesian Therapeutics Announces New Employment Inducement Grants (GlobeNewswire) -9.18%
Jan-22-24 09:19AM	Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today? (InvestorPlace)
Jan-08-24 07:10AM	Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity (GlobeNewswire) +5.87%
07:00AM	Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis (GlobeNewswire)
08:05AM	Loading…
Nov-13-23 08:05AM	Selecta Biosciences Announces Merger with Cartesian Therapeutics (GlobeNewswire) -8.00%
Oct-31-23 04:03PM	Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi (GlobeNewswire)
Aug-24-23 06:21AM	The Petri Dish: Selecta gets selective with drug programs; Moderna enters 2nd cancer vaccine collab (American City Business Journals)
Aug-17-23 10:20PM	Q2 2023 Selecta Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
08:15AM	Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics (GlobeNewswire)
Jul-14-23 07:08AM	Selecta Biosciences, Inc.'s (NASDAQ:SELB) largest shareholders are individual investors with 35% ownership, institutions own 26% (Simply Wall St.)
Jul-13-23 03:00PM	10 Best Revenue Growth Stocks to Buy (Insider Monkey)
Jun-03-23 08:20AM	Selecta Biosciences (NASDAQ:SELB) shareholders are up 22% this past week, but still in the red over the last five years (Simply Wall St.)
May-31-23 07:00AM	Selecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of Rheumatology (GlobeNewswire)
May-09-23 06:06AM	Newsflash: Selecta Biosciences, Inc. (NASDAQ:SELB) Analysts Have Been Trimming Their Revenue Forecasts (Simply Wall St.)
May-04-23 08:45AM	Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -6.96%
07:30AM	Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-28-23 04:05PM	Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update (GlobeNewswire)
Apr-18-23 06:11AM	Investors Holding Back On Selecta Biosciences, Inc. (NASDAQ:SELB) (Simply Wall St.)
07:07AM	Loading…
Mar-27-23 07:07AM	Is Selecta Biosciences, Inc.'s (NASDAQ:SELB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? (Simply Wall St.) -5.67%
Mar-21-23 11:48AM	Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year (Benzinga)
03:30AM	Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Primary Endpoint (GlobeNewswire)
Mar-06-23 05:59AM	Selecta Biosciences, Inc. (NASDAQ:SELB) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-03-23 01:24AM	Q4 2022 Selecta Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-02-23 09:25AM	Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Selecta Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Feb-23-23 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Update (GlobeNewswire)
Feb-07-23 01:51PM	The 7 Best Biotech Stocks to Buy for February 2023 (InvestorPlace)
08:00AM	Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-31-23 01:15PM	Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts (Benzinga)
Jan-17-23 11:33AM	Positive week for Selecta Biosciences, Inc. (NASDAQ:SELB) institutional investors who lost 34% over the past year (Simply Wall St.)
Jan-12-23 05:39AM	The Petri Dish: Moderna looks at new price tag for Covid vaccine (American City Business Journals) +5.44%
Jan-09-23 08:00AM	Selecta Biosciences Provides Business Update and Outlook for 2023 (GlobeNewswire) +8.13%
07:30AM	Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease (PR Newswire)
Dec-21-22 10:29AM	Shareholders in Selecta Biosciences (NASDAQ:SELB) have lost 89%, as stock drops 19% this past week (Simply Wall St.)
Dec-14-22 08:00AM	Selecta Biosciences Announces Next Generation IgA Protease Clinical Candidate Selection for IgA Nephropathy Program (GlobeNewswire)
Dec-01-22 05:43AM	The Petri Dish: bluebird gets $102M; BMS vet joins Selecta's C-suite (American City Business Journals)
Nov-28-22 08:00AM	Selecta Biosciences Announces Appointment of Blaine Davis as Chief Financial Officer (GlobeNewswire)
Nov-09-22 06:36AM	Selecta Biosciences Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.) -8.39%
Nov-07-22 08:00AM	Selecta Biosciences to Participate at the Guggenheim Healthcare Talks \| 4th Annual Immunology & Neurology Day (GlobeNewswire)
Nov-03-22 09:15AM	Selecta Biosciences, Inc. (SELB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
08:00AM	Selecta Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-27-22 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
Oct-18-22 06:13AM	Could The Market Be Wrong About Selecta Biosciences, Inc. (NASDAQ:SELB) Given Its Attractive Financial Prospects? (Simply Wall St.)
Oct-11-22 08:00AM	Selecta Biosciences Announces Three Presentations at the Upcoming 29th Annual European Society of Gene and Cell Therapy (ESGCT) Conference (GlobeNewswire) +7.89%
Oct-10-22 06:10PM	Elevance Health's (ELV) Low-Cost MA Plans to Widen U.S. Base (Zacks) -7.88%
Sep-29-22 08:00AM	Selecta Biosciences Board Member, Timothy Springer, Ph.D., Wins Lasker Award for Seminal Discovery of Key Adhesion Molecules that Mediate Immune Cell Interactions (GlobeNewswire) -5.29%
Sep-12-22 08:00AM	Selecta Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-06-22 08:00AM	Selecta Biosciences to Participate at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-30-22 06:21AM	Selecta Biosciences (NASDAQ:SELB) Has A Pretty Healthy Balance Sheet (Simply Wall St.)
Aug-29-22 05:08PM	This Small-Cap Biotech is a Sneaky Play on Next-Gen Drugs (TheStreet.com)
Aug-12-22 09:30AM	10 Best One Dollar Stocks To Buy Now (Insider Monkey)
Aug-09-22 10:25AM	Need To Know: Analysts Are Much More Bullish On Selecta Biosciences, Inc. (NASDAQ:SELB) (Simply Wall St.)
Aug-06-22 08:25AM	What Kind Of Investors Own Most Of Selecta Biosciences, Inc. (NASDAQ:SELB)? (Simply Wall St.)
Aug-04-22 09:05AM	Selecta Biosciences, Inc. (SELB) Q2 Earnings and Revenues Surpass Estimates (Zacks) +13.94%
07:30AM	Selecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-22 08:00AM	Selecta Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-28-22 12:00PM	Selecta Biosciences, Inc. (SELB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
Jul-19-22 09:19AM	Top 10 Multibagger Penny Stocks to Buy in 2022 (Insider Monkey)
Jul-14-22 09:03AM	Strong week for Selecta Biosciences (NASDAQ:SELB) shareholders doesn't alleviate pain of five-year loss (Simply Wall St.) -7.34%
Jul-12-22 07:49AM	Vertex (VRTX) to Buy ViaCyte to Speed Up VX-880 Program (Zacks) +8.07%
Jul-06-22 08:00AM	Selecta Biosciences to Participate at the Guggenheim I&I Spotlight Series Treg-based Therapies Conference (GlobeNewswire)
Jun-29-22 07:00AM	Surface Oncology Appoints Carsten Brunn to Board of Directors (GlobeNewswire)
Jun-20-22 07:43AM	BioMarin (BMRN) Stock Jumps 5.4%: Will It Continue to Soar? (Zacks)
Jun-14-22 08:59AM	Some Analysts Just Cut Their Selecta Biosciences, Inc. (NASDAQ:SELB) Estimates (Simply Wall St.) -6.25%
Jun-13-22 07:30AM	Selecta Biosciences Announces Partnership Advancements and Clinical Trial Updates (GlobeNewswire)
Jun-10-22 03:26PM	Why Wall Street Doubts This Biotech Penny Stock Will Be Delisted (TheStreet.com) -7.32%
Jun-06-22 02:47PM	SVB Leerink Sees Over 600% Upside For This Penny Biotech Stock (Benzinga) +13.13%
May-19-22 06:00PM	7 Cheap Biotech Stocks to Buy Now (InvestorPlace)
May-17-22 08:00AM	Selecta Biosciences to Participate at the H.C. Wainwright Global Investment Conference (GlobeNewswire) +9.23%
May-10-22 03:23PM	Could The Market Be Wrong About Selecta Biosciences, Inc. (NASDAQ:SELB) Given Its Attractive Financial Prospects? (Simply Wall St.)
May-05-22 08:45AM	Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Selecta Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-02-22 04:30PM	Selecta Biosciences Announces Six Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) (GlobeNewswire)
Apr-28-22 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
Apr-06-22 06:56PM	Selecta Biosciences Announces $38.7 Million Underwritten Offering (GlobeNewswire)
Apr-04-22 08:00AM	Selecta Biosciences to Participate at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-10-22 09:25AM	Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Selecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire)
Mar-09-22 08:45AM	Amryt Pharma PLC Sponsored ADR (AMYT) Tops Q4 Earnings Estimates (Zacks) +10.76%
Mar-03-22 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Provide Business Update (GlobeNewswire)
Feb-09-22 08:00AM	Selecta Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference (GlobeNewswire)
Jan-11-22 11:48AM	Horizon (HZNP) Submits sBLA for Krystexxa Label Expansion (Zacks)
11:21AM	Selecta taps Ginkgo for deal worth up to $1.1B (American City Business Journals)
Jan-10-22 07:00AM	Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids (PR Newswire)
Jan-05-22 08:00AM	Selecta Biosciences to Participate at the 2022 H.C. Wainwright BioConnect Conference (GlobeNewswire)
Dec-29-21 08:00AM	Selecta Biosciences to Participate at the LifeSci Partners 11th Annual Corporate Access Event (GlobeNewswire)
Dec-12-21 07:05AM	Trade Alert: The Independent Chairman Of Selecta Biosciences, Inc. (NASDAQ:SELB), Carrie Cox, Has Just Spent US$51k Buying 26% More Shares (Simply Wall St.)

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides RNA cell therapies for the treatment of autoimmune diseases. The company is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SPRINGER TIMOTHY A	Director	Mar 26 '24	Option Exercise	1.46	1,970,443	2,876,847	33,043,849	Mar 26 04:32 PM
SPRINGER TIMOTHY A	Director	Mar 18 '24	Buy	0.60	19,044	11,398	31,073,406	Mar 20 05:09 PM
SPRINGER TIMOTHY A	Director	Mar 18 '24	Buy	0.61	800	488	104,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 15 '24	Buy	0.59	537,500	314,545	31,054,362	Mar 18 05:29 PM
SPRINGER TIMOTHY A	Director	Mar 15 '24	Buy	0.56	1,200	672	104,018	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 14 '24	Buy	0.54	648,372	351,677	30,516,862	Mar 18 05:29 PM
SPRINGER TIMOTHY A	Director	Mar 14 '24	Buy	0.53	2,000	1,061	102,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 13 '24	Buy	0.58	3,200	1,868	100,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 12 '24	Buy	0.61	1,200	735	97,618	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 11 '24	Buy	0.65	1,200	785	96,418	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 08 '24	Buy	0.66	4,800	3,187	95,218	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Feb 07 '24	Buy	0.66	2,400	1,575	90,418	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Feb 06 '24	Buy	0.65	800	520	88,018	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Jan 17 '24	Buy	0.69	800	552	87,218	Mar 28 05:11 PM
Brunn Carsten	President and CEO	Sep 25 '23	Sale	1.06	2,932	3,108	783,081	Sep 26 06:01 PM
TRABER PETER G	Chief Medical Officer	Sep 25 '23	Sale	1.06	705	747	451,826	Sep 26 06:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RNAC

Cartesian Therapeutics Inc

Upgrade your FINVIZ experience